TEARSCIENCE, INC.
MILPITAS, CA

TearScience Inc., initially a pioneer in the development of LipiFlow, offered a drug-free solution for Dry Eye disease. Notably acquired by Abbott Medical Optics Inc. (AMO), it eventually integrated with Johnson & Johnson Vision, combining forces with the acclaimed ACUVUE® Brand Contact Lenses business. The company's products have catered to emerging trends in cosmetic and functionality lenses that enhance vision and aesthetics, while emphasizing the significance of eye care through professional fittings given the sensitivity of eyes. Headquartered in Milpitas, California, TearScience Inc. was officially incorporated on September 27, 2011, operating under a Florida Incorporation number F11000003886 as designated by a For-Profit (FORP) Company Type. The company's mailing address is listed at 510 Cottonwood Drive, Milpitas, CA, 95035, and it maintains its registered status in Florida with Broward County jurisdiction. The principal state of business filing is Delaware. TearScience’s operational activities emphasize innovation within the ophthalmological sector, focusing on enhancing ocular health through advanced technology ensuring quality tear production and eye protection. As stated on its website, tearscience.com, their commitment extends to contributing positively to customers' visual experience and lifestyle. The company's executive team consists of Lori A. Tierney as President, Matthew Foster serving as Vice President, and Mark Olkiewicz in the role of Treasurer. With a current annual report filed for April 20, 2024, TearScience remains active with several contact numbers available at (919) 459-4891; (919) 459-4880; (919) 459-4890; and (919) 459-4803 for communication purposes. The organization continues to innovate within its field aligned under the branding of Johnson & Johnson Vision, furthering advancements in eye care solutions worldwide.